Eric Shaff

Eric Shaff

Amministratore Delegato presso SERES THERAPEUTICS, INC.

Patrimonio netto: 140 698 $ in data 31/07/2023

48 anni
Health Technology
Consumer Services
Finance

Profilo

Eric D.
Shaff
is currently the President, Chief Executive Officer & Director at Seres Therapeutics, Inc. He previously served as an Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023.
Eric also worked as a Principal at Pfizer Inc. and as the Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011.
He was the Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014.
Prior to that, Eric worked as a Senior Analyst at Broadview International LLC.
He completed his undergraduate studies at the University of Pennsylvania and holds an MBA from the Johnson Graduate School of Management.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/05/2024 140 698 ( 0.09% ) 140 698 $ 31/05/2024
11/08/2023 0 ( -.--% ) - $ 31/07/2023

Posizioni attive di Eric Shaff

SocietàPosizioneInizio
SERES THERAPEUTICS, INC. Amministratore Delegato 15/01/2019
Tutte le posizioni attive di Eric Shaff

Precedenti posizioni note di Eric Shaff

SocietàPosizioneFine
SIGILON THERAPEUTICS, INC. Direttore/Membro del Consiglio 11/08/2023
MOMENTA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/11/2014
Corporate Officer/Principal 01/12/2011
PFIZER, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Eric Shaff

Formazione di Eric Shaff

University of Pennsylvania Undergraduate Degree
Johnson Graduate School of Management Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eric Shaff

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
SERES THERAPEUTICS, INC.

Health Technology

PFIZER, INC.

Health Technology

SIGILON THERAPEUTICS, INC.

Health Technology

Aziende private3

Health Technology

Finance

Health Technology

Vedi le connessioni aziendali